Does SOMATROGON-GHLA Cause Lipodystrophy acquired? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Lipodystrophy acquired have been filed in association with SOMATROGON-GHLA. This represents 1.1% of all adverse event reports for SOMATROGON-GHLA.
12
Reports of Lipodystrophy acquired with SOMATROGON-GHLA
1.1%
of all SOMATROGON-GHLA reports
0
Deaths
0
Hospitalizations
How Dangerous Is Lipodystrophy acquired From SOMATROGON-GHLA?
Of the 12 reports.
Is Lipodystrophy acquired Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SOMATROGON-GHLA. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does SOMATROGON-GHLA Cause?
Injection site pain (738)
Wrong technique in device usage process (43)
Injection site erythema (42)
Incorrect dose administered by device (41)
Injection site swelling (38)
Off label use (29)
Patient-device incompatibility (29)
Headache (27)
Needle issue (27)
Device mechanical issue (24)
What Other Drugs Cause Lipodystrophy acquired?
LAMIVUDINE (383)
ZIDOVUDINE (313)
NEVIRAPINE (288)
STAVUDINE (283)
RITONAVIR (254)
LOPINAVIR\RITONAVIR (230)
DIDANOSINE (216)
TENOFOVIR DISOPROXIL (205)
EFAVIRENZ (203)
INDINAVIR (195)
Which SOMATROGON-GHLA Alternatives Have Lower Lipodystrophy acquired Risk?
SOMATROGON-GHLA vs SOMATROPIN
SOMATROGON-GHLA vs SPIRAMYCIN
SOMATROGON-GHLA vs SUFENTANIL
SOMATROGON-GHLA vs SULBACTAM
SOMATROGON-GHLA vs SULFAMETHOXAZOLE\TRIMETHOPRIM